Skip to main content
Log in

The intraocular pressure response of glaucomatous eyes to topically applied bupranolol

A pilot study

  • Published:
Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie Aims and scope Submit manuscript

Summary

Bupranolol 0.5% oily solution applied topically lowered intraocular pressure of glaucomatous eyes significantly. The pressure decrease is related to pre-treatment pressure levels. The maximum effect occurred within 4 hours and lasted for more than 24 hours. No objective or subjective irritation could be attributed to the ophthalmic preparation. There was no significant effect on outflow facility, on blood pressure or tear flow. However, bupranolol produces local anesthesia on the eye. The problem of tachyphylaxis is discussed in the treatment of glaucoma with bupranolol eye drops.

Zusammenfassung

Die ölige Lösung von 0,5% Bupranolol bewirkt bei lokaler Applikation am Auge eine signifikante Augendrucksenkung um durchschnittlich 42 % des Ausgangsdruckes. Das Maximum der Drucksenkung war nach 4 Stunden zu beobachten, die Drucksenkung nach einmaliger Applikation dauerte mehr als 24 Stunden. Die verwendeten Bupranolol-Augentropfen führten zu keiner Reizung der vorderen Augenabschnitte. Es fand sich kein signifikanter Effekt auf die Abflußleichtigkeit, auf den Blutdruck oder den Tränenfluß. Bupranolol bewirkt jedoch eine Lokalanaesthesie am Auge. Das Problem eines langsamen Wirkungsverlustes von Bupranolol-Augentropfen als Glaukom-Therapeutikum wird diskutiert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bonomi, I., Steindler, P.: Effect of pindolol on intraocular pressure. Brit. J. Ophthal. 59, 301–303 (1975)

    Google Scholar 

  • Elliot, M.J., Cullen, P.M., Philipps, C.I.: Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). Brit. J. Ophthal. 59, 296–300 (1975)

    Google Scholar 

  • Katz, I.M., Hubbard, W.A., Getson, A.J., Gould, A.L.: Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest. Ophthal. 15, 489–492 (1976)

    Google Scholar 

  • Rahi, A.H.S., Chapman, C.M., Gerner, A., Wright, P.: Pathology of practolol-induced ocular toxicity. Brit. J. Ophthal. 60, 312–323 (1976)

    Google Scholar 

  • Sharaf, E.D., Haroun, E.A., Ishaac, Z., El Shewy, T.M., Nassel, A.E.H.: The effect of some β-adrenergic blockers on human intraocular pressure. Exp. Eye Res. 19, 223–225 (1974)

    Google Scholar 

  • Vale, J., Gibbs, A.C.C., Philipps, C.I.: Topical propranolol and ocular tension in the human. Brit. J. Ophthal. 56, 770–775 (1972)

    Google Scholar 

  • Waterloh, E., Rittel, H.-F., Leide, E.: Untersuchungen über 1-(6′-Chlor-3′-methylphenoxy)-3-tert.-butylamino-propan-2-ol-hydrochlorid (KL 255). Arzneimittel-Forsch. 19, 153–156, 330–333 (1969)

    Google Scholar 

  • Willems, D., Frisch, P., Klepzig, H.: Behandlung von Angina pectoris und Herzrhytmusstörungen mit einem Beta-Rezeptorenblocker. Zeitschr. Kreislaufforsch. 60, 309–318 (1971)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The authors are indebted to Dr. Winzer, chem.-pharm. Fabrik, Konstanz, for a generous supply of bupranolol in oily solution (OphthoreninR), and to Ms. E. Profitlich for able technical assistance.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krieglstein, G.K., Sold-Darseff, J. & Leydhecker, W. The intraocular pressure response of glaucomatous eyes to topically applied bupranolol. Albrecht von Graefes Arch. Klin. Ophthalmol. 202, 81–86 (1977). https://doi.org/10.1007/BF00410994

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00410994

Keywords

Navigation